AI environmental concerns build as lawmakers grapple with tech panic26m ago Claude comes for Gemini with its own take on Docs and Slides1h ago At UN, Nations Wrestle With the Rise of Autonomous Weapons39m ago Anthropic official says she’s hearing from her mom about AI safety41m ago Secure Compute and Static IP builds start 64% faster43m ago Mem0 joins the Vercel Marketplace43m ago Google will now let any AI agent run your smart home43m ago Your AI agents can now control your Google Home devices43m ago Anthropic Launches Claude For Advisors With Schwab And BlackRock46m ago No consent for large AI data centres before Christmas, MSPs told51m ago Rethinking Robot Safety in the Age of AI52m ago Only 6% Of Companies Get Value From AI. Here’s What They Do Differently58m ago Apple planning to sell AI servers powered by M8 Ultra chips, says report1h ago Arcee AI built Trinity for about $20m, and investors now value it at $1bn+1h ago

AI environmental concerns build as lawmakers grapple with tech panic26m ago Claude comes for Gemini with its own take on Docs and Slides1h ago At UN, Nations Wrestle With the Rise of Autonomous Weapons39m ago Anthropic official says she’s hearing from her mom about AI safety41m ago Secure Compute and Static IP builds start 64% faster43m ago Mem0 joins the Vercel Marketplace43m ago Google will now let any AI agent run your smart home43m ago Your AI agents can now control your Google Home devices43m ago Anthropic Launches Claude For Advisors With Schwab And BlackRock46m ago No consent for large AI data centres before Christmas, MSPs told51m ago Rethinking Robot Safety in the Age of AI52m ago Only 6% Of Companies Get Value From AI. Here’s What They Do Differently58m ago Apple planning to sell AI servers powered by M8 Ultra chips, says report1h ago Arcee AI built Trinity for about $20m, and investors now value it at $1bn+1h ago

Healthcare3 min reading time

Novo will test Anthropic’s Claude Science to speed up drug discovery

Covered by 4 sourcesPublished 1 hour ago

Novo, the Danish drugmaker, has partnered with Anthropic to use its AI models, including Claude Science, to accelerate drug discovery and development. Novo will test Claude Science in R&D workflows to enhance productivity and shorten research timelines.

Covered by 4 sources

#anthropic #claude-science #drug-discovery #novo #pharmaceutical-research

More in Healthcare

Novo Will Work With Anthropic AI to Speed Drug Development

Covered by 4 sources4h ago

Healthcare6 min read

New AI technique could make minimally invasive surgeries safer and more precise

MIT AI News3h ago

Healthcare2 min read

ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports

The Next Web10h ago